⌘K

Login Start Free

Home/Filings/4/0000899243-22-018133

4//SEC Filing

Mamluk Roni 4

Accession 0000899243-22-018133

CIK 0001797336other

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:10 PM ET

Size

4.7 KB

Accession

0000899243-22-018133

Insider Transaction Report

Form 4

Period: 2022-05-16

Ayala Pharmaceuticals, Inc.AYLA

DirectorCEO

Transactions

Award
Common Stock
2022-05-16+120,000→ 265,345 total

Footnotes (1)

[F1]Represents an award of restricted common stock, which will vest quarterly over a period of three years from May 16, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ayala Pharmaceuticals, Inc.

CIK 0001797336

Entity typeother

Related Parties

1

filerCIK 0001647053

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 4:10 PM ET
Size: 4.7 KB

View on SEC.gov